Medications for Metabolic Diseases

4 results

  • bioferr 90

    (Dual-Iron)
    Biocon Pharma Inc.
    BioFerr™ 90 is indicated for treating all anemias responsive to oral iron therapy, including hypochromic anemia related to pregnancy, blood loss (acute or chronic), metabolic diseases, post-surgical recovery, and dietary deficiencies.

  • fludeoxyglucose f 18

    (Fludeoxyglucose F 18 Injection)
    Northland Nuclear Medicine
    Fludeoxyglucose F 18 Injection is indicated for PET imaging to identify abnormal glucose metabolism in epilepsy, assess malignancy in cancer patients, and evaluate coronary artery disease with left ventricular dysfunction alongside myocardial perfusion imaging. It is not suitable for differentiating epileptogenic foci from other brain lesions.

  • fludeoxyglucose f 18

    (Fludeoxyglucose F-18)
    Mayo Clinic
    Fludeoxyglucose F 18 Injection USP is indicated for PET imaging to evaluate malignancy, assess glucose metabolism in coronary artery disease and left ventricular dysfunction, and identify abnormal glucose metabolism related to epileptic seizures.

  • neonatal fe

    (iron, folic acid, cyanocobalamin, ascorbic acid)
    SLV PHARMACEUTICALS LLC DBA AUM PHARMACEUTICALS
    NEONATAL FE Rx Prenatal Vitamin with ferronyl iron is indicated for treating anemias responsive to oral iron therapy, including hypochromic anemia due to pregnancy, blood loss, metabolic disease, postsurgical recovery, and dietary deficiencies.